Delays in Time to Treatment and Survival Impact in Breast Cancer
| Autor: | Jordan M. Estroff, Roshni Rao, Valerie Andrews, A. Marilyn Leitch, Amy Brazda, James F. Huth, Amy Moldrem, David M. Euhus |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Oncology
medicine.medical_specialty Time Factors Population Breast Neoplasms Cohort Studies Breast cancer Surgical oncology Internal medicine medicine Humans Stage (cooking) education Survival rate Neoplasm Staging Retrospective Studies education.field_of_study business.industry Cancer Retrospective cohort study Prognosis medicine.disease Survival Rate Female Surgery business Follow-Up Studies Cohort study |
| Zdroj: | Annals of Surgical Oncology. 17:291-296 |
| ISSN: | 1534-4681 1068-9265 |
| DOI: | 10.1245/s10434-010-1250-6 |
| Popis: | Time interval from diagnosis of breast cancer to treatment has been promulgated as one factor that can be used to evaluate cancer care quality. It remains controversial, however, whether a delay to treatment impacts survival. The purpose of this study was to evaluate whether delays from diagnosis to initial treatment in breast cancer impacts survival. A retrospective review of patients undergoing breast cancer treatment between August 2005 and December 2008 in a comprehensive, multidisciplinary breast oncology program was undertaken. Two hospital systems were included: a county hospital (CH) treating a primarily minority, indigent population and a university hospital (UH) treating a primarily Caucasian, insured population. Interval to treatment, calculated from date of diagnosis to surgery, chemotherapy, or radiation treatment, and overall survival was compared between the two groups. A total of 1337 patients were included; 634 patients were treated in the CH and 703 in the UH. Interval to treatment was longer in the CH compared with the UH (53.4 ± 2.0 vs 33.2 ± 1.2 days; mean ± standard error of the mean [SEM], P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink